Iakovou K - Search Results

1

Targeted therapy in oncology patients and skin: Pharmaceutical and dermocosmetic management.

Varvaresou A, Iakovou K, Mellou F, Myrogiannis D, Papageorgiou S. Varvaresou A, et al. Among authors: iakovou k. J Cosmet Dermatol. 2020 Apr;19(4):782-788. doi: 10.1111/jocd.13211. Epub 2019 Nov 26. J Cosmet Dermatol. 2020. PMID: 31769600 Review.

2

Biosurfactants in cosmetics and biopharmaceuticals.

Varvaresou A, Iakovou K. Varvaresou A, et al. Among authors: iakovou k. Lett Appl Microbiol. 2015 Sep;61(3):214-23. doi: 10.1111/lam.12440. Epub 2015 Jun 25. Lett Appl Microbiol. 2015. PMID: 25970073

3

Molecular modeling study of intercalation complexes of tricyclic carboxamides with d(CCGGCGCCGG)₂ and d(CGCGAATTCGCG)₂.

Varvaresou A, Iakovou K. Varvaresou A, et al. Among authors: iakovou k. J Mol Model. 2011 Aug;17(8):2041-50. doi: 10.1007/s00894-010-0891-5. Epub 2010 Dec 14. J Mol Model. 2011. PMID: 21153908

4

Synthesis, antiretroviral and antioxidant evaluation of a series of new benzo[b]furan derivatives.

Varvaresou A, Iakovou K, Filippatos E, Souli C, Calogeropoulou T, Ioannidou I, Kourounakis AP, Pannecouque C, Witvrouw M, Padalko E, Neyts J, De Clercq E, Tsotinis A. Varvaresou A, et al. Among authors: iakovou k. Arzneimittelforschung. 2001 Feb;51(2):156-62. doi: 10.1055/s-0031-1300018. Arzneimittelforschung. 2001. PMID: 11258046

5

Design, synthesis and biological evaluation of novel beta-substituted indol-3-yl ethylamido melatoninergic analogues.

Iakovou K, Varvaresou A, Kourounakis AP, Stead K, Sugden D, Tsotinis A. Iakovou K, et al. J Pharm Pharmacol. 2002 Jan;54(1):147-56. doi: 10.1211/0022357021771869. J Pharm Pharmacol. 2002. PMID: 11829126

6

Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.

Varvaresou A, Iakovou K, Gikas E, Fichtner I, Fiebig HH, Kelland LR, Double JA, Bibby MC, Hendriks HR. Varvaresou A, et al. Among authors: iakovou k. Anticancer Res. 2004 Mar-Apr;24(2B):907-19. Anticancer Res. 2004. PMID: 15161044 Free article.

7

Struggle for the future health of adolescent patients with phenylketonuria and parents with a sick child due to the economic crisis.

Iakovou K. Iakovou K. J Pediatr Endocrinol Metab. 2024 Mar 5;37(4):365-366. doi: 10.1515/jpem-2024-0075. Print 2024 Apr 25. J Pediatr Endocrinol Metab. 2024. PMID: 38436328 No abstract available.

8

The effect of phenylketonuria on family quality of life.

Iakovou KK. Iakovou KK. J Pediatr Endocrinol Metab. 2024 Mar 5;37(4):363-364. doi: 10.1515/jpem-2024-0081. Print 2024 Apr 25. J Pediatr Endocrinol Metab. 2024. PMID: 38436325 No abstract available.

9

Self-estimation of phenylketonuria patients on therapeutic diet. Psychological support.

Iakovou KK, Schulpis K. Iakovou KK, et al. Drug Metab Pers Ther. 2020 Jun 30;35(2):/j/dmdi.2020.35.issue-2/dmpt-2020-0107/dmpt-2020-0107.xml. doi: 10.1515/dmpt-2020-0107. Drug Metab Pers Ther. 2020. PMID: 32681775 Clinical Trial.

10

Self-estimation of phenylketonuria patients on therapeutic diet. Psychological support.

Iakovou KK, Schulpis K. Iakovou KK, et al. Drug Metab Pers Ther. 2020 Jun 30:/j/dmdi.ahead-of-print/dmdi-2020-0107/dmdi-2020-0107.xml. doi: 10.1515/dmdi-2020-0107. Online ahead of print. Drug Metab Pers Ther. 2020. PMID: 32609648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page